These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37869533)

  • 1. Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East.
    Ali S; Al Bukhari F; Al Nuaimi K; Elenany H; Fakih-Gomez N; Ghannam S; Haidar R; Isse N; Labib N; Mosahebi A; Ravichandran S; Turkmani MG; Youssef C
    Clin Cosmet Investig Dermatol; 2023; 16():2899-2909. PubMed ID: 37869533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations.
    Kane M; Donofrio L; Ascher B; Hexsel D; Monheit G; Rzany B; Weiss R
    J Drugs Dermatol; 2010 Jan; 9(1 Suppl):s7-22; quiz s23-5. PubMed ID: 20919448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part II: incorporating botulinum toxin into aesthetic clinical practice.
    Carruthers J; Fournier N; Kerscher M; Ruiz-Avila J; Trindade de Almeida AR; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):510-25. PubMed ID: 23458295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
    Wortzman MS; Pickett A
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The convergence of medicine and neurotoxins: a focus on botulinum toxin type A and its application in aesthetic medicine--a global, evidence-based botulinum toxin consensus education initiative: part I: botulinum toxin in clinical and cosmetic practice.
    Carruthers A; Kane MA; Flynn TC; Huang P; Kim SD; Solish N; Kaeuper G
    Dermatol Surg; 2013 Mar; 39(3 Pt 2):493-509. PubMed ID: 23458294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations.
    Carruthers JDA; Glogau RG; Blitzer A;
    Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A; Shafer D
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations.
    Yutskovskaya Y; Gubanova E; Khrustaleva I; Atamanov V; Saybel A; Parsagashvili E; Dmitrieva I; Sanchez E; Lapatina N; Korolkova T; Saromytskaya A; Goltsova E; Satardinova E
    Clin Cosmet Investig Dermatol; 2015; 8():297-306. PubMed ID: 26089695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAMCEP Society consensus on the treatment of upper facial lines with botulinum neurotoxin type A: A tailored approach.
    Braccini F; Catoni I; Belfkira F; Lagier J; Roze E; Paris J; Huth J; Bronsard V; Cartier H; David M; Galatoire O; Obadia D; Sabatier H; Sarfati E; Kestemont P; Winter C; Redaelli A
    J Cosmet Dermatol; 2023 Oct; 22(10):2692-2704. PubMed ID: 37408173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New botulinum toxins for aesthetic dermatology : A comprehensive review].
    Patil A; Kassir M; Wollina U; Goldust M
    Hautarzt; 2021 May; 72(5):393-402. PubMed ID: 33822278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical equivalence of conventional OnabotulinumtoxinA (900 KDa) and IncobotulinumtoxinA (neurotoxin free from complexing proteins - 150 KDa): 2012 multidisciplinary French consensus in aesthetics.
    Poulain B; Trevidic P; Clave M; Aharoni C; Baspeyras M; Bui P; Cartier H; Charavel MH; Coulon P; Dahan S; Dallara JM; Delonca D; Dumas L; Essayagh E; Galatoire O; Georgieu N; Grangier Y; Humbert P; Le Pillouer-Prost A; Mojallal A
    J Drugs Dermatol; 2013 Dec; 12(12):1434-46. PubMed ID: 24301246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aesthetic Applications of Botulinum Toxin A in Asians: An International, Multidisciplinary, Pan-Asian Consensus.
    Sundaram H; Huang PH; Hsu NJ; Huh CH; Wu WT; Wu Y; Cassuto D; Kerscher MJ; Seo KK;
    Plast Reconstr Surg Glob Open; 2016 Dec; 4(12):e872. PubMed ID: 28293488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
    Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
    Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for cosmetic treatments in young adults: An evidence-based review and survey on current practice among aesthetic practitioners.
    Michon A
    J Cosmet Dermatol; 2023 Jan; 22(1):128-139. PubMed ID: 36445847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of botulinum neurotoxins.
    Lowe NJ
    J Cosmet Laser Ther; 2007; 9 Suppl 1():11-6. PubMed ID: 17885881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.
    Carruthers J; Fagien S; Matarasso SL;
    Plast Reconstr Surg; 2004 Nov; 114(6 Suppl):1S-22S. PubMed ID: 15507786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of botulinum neurotoxin type A for cosmetic applications.
    Carruthers J; Carruthers A
    J Cosmet Laser Ther; 2007 Sep; 9(3):186-92. PubMed ID: 17763029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus on Current Injectable Treatment Strategies in the Asian Face.
    Wu WTL; Liew S; Chan HH; Ho WWS; Supapannachart N; Lee HK; Prasetyo A; Yu JN; Rogers JD;
    Aesthetic Plast Surg; 2020 Aug; 44(4):1195-1207. PubMed ID: 32844269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.
    Boulias C; Ismail F; Phadke CP; Bagg S; Bureau I; Charest S; Chen R; Cheng A; Ethans K; Fink M; Finlayson H; Gulasingam S; Guo M; Haziza M; Hosseini H; Khan O; Lang M; Lapp T; Leckey R; Li Pi Shan R; Liem N; Lo A; Mason M; McNeil S; McVeigh S; Miller T; Mills PB; Naud P; O'Connell C; Petitclerc M; Prevost J; Reebye R; Richardson D; Satkunam L; Sharma S; Short C; Sirois G; Unarket M; Wein T; Wilkins K; Winston P
    Arch Phys Med Rehabil; 2018 Nov; 99(11):2183-2189. PubMed ID: 29803825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.